Clinical & translational oncology

• 

  Año 2024, Vol. 26, Número 9

  • REVIEW ARTICLE

    • Association between thyroid disorders and extra‑thyroidal cancers, a review

      Xin Jia, Jingru Li, Zongliang Jiang

      • Resumen

      págs. 2075-2083

      

    • Advances in tumor vascular growth inhibition

      Keyong Zhang, Yuanyuan Shi, Ze Jin, Jian He

      • Resumen

      págs. 2084-2096

      

    • Current status of neoadjuvant immunotherapy for the treatment of gastric cancer

      Xijie Zhang, Bo Liu, Rui Wang, Wence Zhou, Xin Li

      • Resumen

      págs. 2097-2108

      

    • Screening and treatment of latent tuberculosis in patients with solid tumors and systemic cancer therapy

      Miguel Borregón Rivilla, David Sanchez Lorente, Elia Martínez Moreno

      • Resumen

      págs. 2109-2115

      

    • A review of dose escalation for FDA‑approved products treating solid tumors and hematological malignancies in first‑in‑human trials

      Zehui Jiang, Wenxuan Sun, Rui Du, Rui Yang

      • Resumen

      págs. 2116-2125

      

    • In vivo safety evaluation method for nanomaterials for cancer therapy

      Mengqi Chen, Jingyi Hei, Yang Huang, Xiyu Liu, Yong Huang

      • Resumen

      págs. 2126-2141

      

    • Evolution of radiation‑induced dermatitis treatment

      Deng Guangmei, He Weishan, Liu Wenya, Wu Fasheng, Chen Jibing

      • Resumen

      págs. 2142-2155

      

    • The role of TET2 in solid tumors and its therapeutic potential: a comprehensive review

      Wenxin Da, Ziyu Song, Xiaodong Liu, Yahui Wang, Shengjun Wang, Jie Ma

      • Resumen

      págs. 2156-2165

      

    • Exploring research progress in studying serum exosomal miRNA‑21 as a molecular diagnostic marker for breast cancer

      Hang Li, Xiao jing Tie

      • Resumen

      págs. 2166-2171

      

  • CLINICAL GUIDES IN ONCOLOGY

    • Logistic regression and other statistical tools in diagnostic biomarker studies

      Dina Mohamed Ahmed Samir Elkahwagy, Caroline Joseph Kiriacos, Manar Mansour

      • Resumen

      págs. 2172-2180

      

  • RESEARCH ARTICLE

    • Integrated analysis reveals an aspartate metabolism‑related gene signature for predicting the overall survival in patients with hepatocellular carcinoma

      Juanyi Shi, Kai Wen, Sintim Mui, Huoming Li, Hao Liao, Chuanchao He, Yongcong Yan, Zhenyu Zhou, Zhiyu Xiao

      • Resumen

      págs. 2181-2197

      

    • Enhanced outcomes in residual or recurrent craniopharyngioma: evaluating combined gamma knife and phosphorus‑32 brachytherapy

      Jie Ma, Gan Gao, Tao Chen, Jianning Zhang, Weidong Cao, Xinguang Yu, Hongwei Wang

      • Resumen

      págs. 2198-2204

      

    • Molecular characterization of Chinese patients with small bowel adenocarcinoma

      Bryan Jin, Bin Lv, Wenshuai Li, Huan Song, Haoshu Cui, Yao Liu, Bin Zhong, Xin Shen, Xiao Li, Wanwei Zheng, Jie Liu, Feifei Luo, Zhongguang Luo, Zhengqing Yan, Bei Zhang, Shiqing Chen

      • Resumen

      págs. 2205-2216

      

    • Real‑world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early‑stage HER2‑positive breast cancer: the NEOPERSUR study

      Alejandro Falcón González, Javier Salvador Boffil, M. Ruiz Borrego, Josefina Cruz Jurado, Rocío Álvarez Ambite, Elisenda Llabres Valentí, Rocío Urbano Cubero, Dina Mohamed Ahmed Samir Elkahwagy, María del Carmen Álamo de la Gala, F. Henao Carrasco, Antonia Martínez Guisado, Carlos José Rodríguez González, Marta Amérigo Góngora, Juan Bayo Calero, Lourdes Rodríguez Pérez, Pilar López Álvarez, Encarnación González Flores, María Valero Arbizu, Alicia Quílez Cutillas, Eloísa Rubio Pérez

      • Resumen

      págs. 2217-2226

      

    • Personalizing non‑small cell lung cancer treatment through patient‑derived xenograft models: preclinical and clinical factors for consideration

      Vered Fuchs, Ariel Sobarzo, Maha Msamra, Angel Porgador, Laila Catalina Roisman, Alaa Anoze, Nir Peled, Yarden Kezerle, Liat Linde, Gur Sevillya, Yael Refaely, Ahron Yehonatan Cohen, Yael Raviv, Israel Melamed, Amit Azriel, Rami Shoukrun

      • Resumen

      págs. 2227-2239

      

    • The effect of metabolic syndrome on prognosis of diffuse large B‑cell lymphoma

      Wenjing Xiong, Liru Li, Xue Hui, Yue Liu, Hongbin Li, Yue Zhang, Shu Zhao

      • Resumen

      págs. 2240-2249

      

    • Potential of semen coicis in enhancing the anti‑tumor effects of PD‑1 inhibitor on A549 cell lines by blocking the PI3K‑AKT‑mTOR pathway

      Zi Yi Fu, Ying Huang, Yan Cai, Le Shen Lian, Hui Ting Huang, Shao Feng Zhan, Xiao Hong Liu, Jun Xiong Li

      • Resumen

      págs. 2250-2261

      

    • Development and validation of a novel scoring system based on a nomogram for predicting inadequate bowel preparation

      Xiaxia Zhao, Jinyong Hao, Jie Feng, Zhongyuan Cui, Huimin Ma, Xiaojun Huang, Yanglin Pan

      • Resumen

      págs. 2262-2273

      

    • Identification and validation of an immune‑derived multiple programmed cell death index for predicting clinical outcomes, molecular subtyping, and drug sensitivity in lung adenocarcinoma

      Chunhong Li, Jiahua Hu, Xiling Jiang, Haiyin Tan, Yiming Mao

      • Resumen

      págs. 2274-2295

      

    • Machine learning‑driven prediction of brain metastasis in lung adenocarcinoma using miRNA profile and target gene pathway analysis of an mRNA dataset

      Young Wha Koh, Jae Ho Han, Seokjin Haam, Hyun Woo Lee

      • Resumen

      págs. 2296-2308

      

    • Construction of a disulfidptosis‑related glycolysis gene risk model to predict the prognosis and immune infiltration analysis of gastric adenocarcinoma

      Zhaohui Liao, Zhengyuan Xie

      • Resumen

      págs. 2309-2322

      

    • Can neoadjuvant systemic therapy provide additional benefits for T1 HER2+ breast cancer patients: a subgroup analysis based on different high‑risk signatures

      Lidan Chang, Dandan Liu, Xuyan Zhao, Luyao Dai, Xueting Ren, Qian Hao, Peinan Liu, Xiaobin Ma, Huafeng Kang, Hao Wu

      • Resumen

      págs. 2323-2338

      

    • Effect of immune checkpoint inhibitors at different treatment time periods on prognosis of patients with extensive‑stage small‑cell lung cancer

      Song Mi, Jiandong Zhang, Xin Liu, Ning Liang, Pingping Hu, Yunxin Yang, Shaotong Tang, Jinyue Sun, Chao Liu, Qidong Ren, Jihong Lu

      • Resumen

      págs. 2339-2350

      

    • ECLIM‑SEHOP: : how to develop a platform to conduct academic trials for childhood cancer

      Antonio Juan Ribelles, María Adela Cañete Nieto, José María Fernández Navarro, María del Mar Andrés, María Toboso Ortega, F. J. Bautista Sirvent, Alba Rubio San Simón, Álvaro Lassaletta Atienza, Blanca Herrero, Anna Alonso Saladrigues, S. Rives Solà, José Luis Dapena, Ofelia Cruz Martínez, R. Hladun, C. Díaz de Heredia Rubio, Lucas Moreno, Gemma Ramírez Villar, Eduardo Quiroga Cantero, Catalina Márquez-Vega, José Luis Fuster Soler, Miguel Alejandro García Ariza, Jaime Verdú Amorós, A. Molinés Honrubia, Mónica López Duarte, Francisco Lendínez Molinos, Jose Gómez Sirvent, María Tallón García, Guiomar Rodríguez Beloso, Tomás Acha García, Ana Fernández-Teijeiro Álvarez

      • Resumen

      págs. 2351-2359

      

    • Clinical features and treatment outcomes of PD‑1 inhibitor therapy in elderly patients (≥ 65 years) with advanced esophageal squamous cell carcinoma: a real‑world study

      Yi Yu, Tao Wu, Can Liu, Ran Zhang, Jinxiu Zheng, Jianping Xiong, Jun Chen, Junhe Li, Wei Gan

      • Resumen

      págs. 2360-2368

      

    • Explainable and visualizable machine learning models to predict biochemical recurrence of prostate cancer

      Wenhao Lu, Rongbin Zhou, Xiao Li, Fubo Wang, Huiyong Zhang, Shaohua Chen, Chenbang Wang, Chunmeng Wei, Zuheng Wang, Lin Zhao, Shenfan Wang, Jin Ji, Kangxian Jiang, Xuedong Wei, Wenlei Hou

      • Resumen

      págs. 2369-2379

      

    • Prevalence and risk factors of thyroid nodules in breast cancer women with different clinicopathological characteristics: a cross‑sectional study

      Chen yu Ma, Xin yu Liang, Rui-Ling Shen, Jun han Feng, Zhi yu Jiang, Zhao xing Li, Xiu quan Qu, Bai qing Peng, Kai nan Wu, Ling quan Kong, Liang Ran, Fan ling Zeng, Lei Hu

      • Resumen

      págs. 2380-2387

      

  • BRIEF RESEARCH ARTICLE

    • Chronological pattern of venous thromboembolism (VTE) occurrence impacts in survival of pancreatic ductal adenocarcinoma (PDAC)

      Irene González Caraballo, Rocío Martín Lozano, Roberto Jiménez Rodríguez, Javier Soto Alsar, Laura Ortega Morán, Miguel Martín Jiménez, Andrés Jesús Muñoz Martín

      • Resumen

      págs. 2388-2392

      

  • CORRECTION

    • Correction: Logistic regression and other statistical tools in diagnostic biomarker studies

      Dina Mohamed Ahmed Samir Elkahwagy, Caroline Joseph Kiriacos, Manar Mansour

      págs. 2393-2393